[1]王丰,杨雄刚,刘永恒,等.骨干假体治疗股骨干转移性病理骨折的临床疗效[J].中华老年骨科与康复电子杂志,2017,(04):197-204.[doi:10.3877/cma.j.issn.2096-0263.2017.04.002]
 Wang Feng,YangXionggang,LiuYongheng,et al.Effectiveness of modular intercalary endoprosthesis for femoral metastatic pathological fracture[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(04):197-204.[doi:10.3877/cma.j.issn.2096-0263.2017.04.002]
点击复制

骨干假体治疗股骨干转移性病理骨折的临床疗效()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2017年04期
页码:
197-204
栏目:
髋部骨折
出版日期:
2017-07-15

文章信息/Info

Title:
Effectiveness of modular intercalary endoprosthesis for femoral metastatic pathological fracture
作者:
王丰 1杨雄刚 1刘永恒 1伦登兴 2张浩 1杨立 1赵立明 1张慧林 1苗军 3胡永成 3
300070 天津医科大学 1;261000 山东省潍坊市人民医院骨科 2;300211 天津医院骨肿瘤科 3
Author(s):
Wang Feng1 YangXionggang1LiuYongheng1LunDengxing2ZhangHao1YangLi1ZhaoLiming1ZhangHuilin1Miao Jun3 Hu Yongcheng3
1Tianjin Medical University, Tianjin 300070, China; 2Department of Orthopedics, Weifang People’sHospital,Weifang261000,China;3DepartmentofBoneOncology,TianjinHospital,Tianjin300211,China
关键词:
骨肿瘤 骨重建 假体植入
Keywords:
Bone neoplasms Bone remodeling Prosthesis implantation
DOI:
10.3877/cma.j.issn.2096-0263.2017.04.002
文献标志码:
A
摘要:
目的 探讨股骨干转移瘤病理性骨折切除后骨干缺损进行骨干假体重建的临床疗效。方法 回顾性分析天津医院骨肿瘤科 2011年 7月至 2016年 3月采用骨干瘤段切除假体置换手术治疗的股骨干转移病理性骨折患者 15例,其中男性 6例,女性 9例,年龄 57~81岁,平均年龄(68±9)岁。记录患者的手术时间、术中出血量及截骨长度,对其预期生存时间及实际生存时间进行评估与对比,并依据国际骨与软组织肿瘤协会(MSTS)标准进行评分。结果 手术用时 70(30)min;出血量 800(200)ml;术中平均截骨长度(9.5±2.4)cm,范围:7~16 cm。病理回报:结肠癌转移 1例,肺癌转移 5例,乳腺癌转移 3例,肾癌转移 3例,肝癌转移 2例,未知来源腺癌转移 1例。随访 2~25个月,中位随访时间 7(6)个月,其中 14例患者死亡,1例患者仍存活。死亡患者中位生存时间为 6.5(5)个月。实际生存时间大于预期生存时间且差异有显著统计学意义(Z=-2.935,P<0.01)。末次随访时,15例患者患肢功能良好,均无局部复发及假体松动,MSTS术后评分平均为(26.0±1.8)分,范围:22~30分。结论 肿瘤瘤段切除骨干假体重建术是治疗股骨干转移病理性骨折的有效术式之一,该术式能够达到安全的外科边界,降低局部复发率,并保留良好的肢体功能。
Abstract:
Objective To explore the clinical effect of group- matched bone prosthesis in the treatment of femoral metastatic pathological fracture and reconstruction of bone defect. Methods Fifteen patients with metastatic carcinoma of femur treated surgically in department of bone oncology, Tianjin Hospital from July 2011 to March 2016 were retrospectively analyzed, including 6 males and 9 females with an average age of 68±9 years (57 to 81). Operation time, intraoperative blood loss and osteotomy length were recorded. The expecting and actual life span was estimated and compared. Results The median operation time was 70(30) min. The median blood loss was 800(200) ml. The mean osteotomy length was 9.5±2.4 cm (7 to 16). The median follow-up was 7(6) months. Fourteen patients deceased and one patient was alive in the last follow up. The median survival was 6.5(5) months for patients deceased. The actual survival time was longer than the expecting survival time by the Dutch model scoring system and difference was significant statistically (Z=-2.935, P<0.05). At the latest follow-up, all patients obtained fine limb function. The mean MSTS score was 26.0 ± 1.8 (22 to 30). No patient had local relapse and prosthesis loosening. Conclusion Modular intercalary endoprosthesis is an effective treatment for segmental defects of femoral metastatic pathological fracture which can achieve safe surgical margins, reduce local recurrence rate and reserve limb function.

参考文献/References:

1 Piccioli A, Rossi B, Scaramuzzo L, et al. Intramedullary nailing for treatment of pathologic femoral fractures due to metastases [J]. Injury, 2014, 45(2): 412-417.
2 Katzer A, Meenen NM, Grabbe F, et al. Surgery of skeletal metastases [J]. Arch Orthop Trauma Surg, 2002, 122(5): 251-258.
3 Bhandari V, Jain RK. A retrospective study of incidence of bone metastasis in head and neck cancer [J]. J Cancer Res Ther, 2013, 9 (1): 90-93.
4 Aaron AD. Treatment of metastatic adenocarcinoma of the pelvis and the extremities [J]. J Bone Joint Surg Am, 1997, 79(6): 917-932.
5 Healey JH, Brown HK. Complications of bone metastases: surgical management [J]. Cancer, 2000, 88(Suppl.12): 2940-2951.
6 Hu YC. Surgical technique for Reconstruction of diaphyseal defect with endoprosthesis following intercalary resection in femoral shaft [J]. Orthop Surg, 2014, 6(4): 329-331.
7 Ruggieri P, Mavrogenis AF, Casadei R, et al. Protocol of surgical treatment of long bone pathological fractures [J]. Injury, 2010, 41 (11): 1161-1167.
8 Nakamura T, Abudu A, Grimer RJ, et al. The clinical outcomes of extracorporeal irradiated and re- implanted cemented autologous bone graft of femoral diaphysis after tumour resection [J]. Int Orthop, 2013, 37(4): 647-651.
9 Mankin HJ, Gebhardt MC, Jennings LC, et al. Long-term results of allograft replacement in the management of bone tumors [J]. Clin Orthop Relat Res, 1996 (324): 86-97.
10 Chang DW, Weber KL. Segmental femur Reconstruction using an intercalary allograft with an intramedullary vascularized fibula bone flap [J]. J Reconstr Microsurg, 2004, 20(3): 195-199.
11 Gebhardt MC, Roth YE, Mankin HJ. Osteochondral allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor [J]. J Bone Joint Surg, 1990, 72(3): 334-345.
12 Ortiz- Cruz E, Gebhardt MC, Jennings LC, et al. The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study [J]. J Bone Joint Surg Am, 1997, 79(1): 97-106.
13 Alman BA, De Bari A, Krajbich JI. Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents [J]. J Bone Joint Surg Am, 1995, 77(1): 54-64.
14 Hattori H, Mibe J, Yamamoto K. Modular megaprosthesis in metastatic bone disease of the femur [J]. Orthopedics, 2011, 34(12): e871-e876.
15 Lempberg R, Ahlgren O. Prosthetic replacement of tumourdestroyed diaphyseal bone in the lower extremity [J]. Acta Orthop Scand, 1982, 53(4): 541-545.
16 Abudu A, Carter SR, Grimer RJ. The outcome and functional results of diaphyseal endoprostheses after tumour excision [J]. J Bone Joint Surg Br, 1996, 78(4): 652-657.
17 Halpern SD, Ubel PA, Caplan AL. Solid- organ transplantation in HIV-infected patients [J]. N Engl J Med, 2002, 347(4): 284-287.
18 Jablonski S. Online multiple congenital anomaly/mental retardation (MCA/Mr)syndromes [DB/OL],1999(2001-11-20).
19 Fuchs B, Ossendorf C, Leerapun T, et al. Intercalary segmental Reconstruction after bone tumor resection [J]. Eur J Surg Oncol, 2008, 34(12): 1271-1276.
20 Benevenia J, Kirchner R, Patterson F, et al. Outcomes of a modular intercalary endoprosthesis as treatment for segmental defects of the femur, tibia, and humerus [J]. Clin Orthop Relat Res, 2016, 474(2): 539-548.
21 Ruggieri P, Mavrogenis AF, Bianchi G, et al. Outcome of the intramedullary diaphyseal segmental defect fixation system for bone tumors [J]. J Surg Oncol, 2011, 104(1): 83-90.
22 金韬, 郝林, 李远, 等. 人工间置型假体置换治疗长骨骨干恶性肿瘤 (附 4 例报告) [J]. 中国骨科临床与基础研究杂志, 2011, 3(4): 267-271.
23 于秀淳, 徐明, 许宋锋, 等. 节段性肿瘤假体治疗长骨骨干转移瘤并病理骨折(2例报道并文献复习) [J]. 中国骨科临床与基础研究杂志, 2011, 3(4): 281-285.
24 钟俊青, 胡永成. 节段型人工假体重建骨干肿瘤切除后缺损的初步报告 [J]. 中华骨科杂志, 2012, 32(4): 378-381.
25 杜路宽, 顾德毅, 徐蔚蔚, 等. 节段性肿瘤假体置换治疗股骨干转移瘤合并病理性骨折 1 例 [J]. 中国骨与关节损伤杂志, 2014, 29(8): 765.
26 Van Der Linden YM, Dijkstra SP, Vonk EJ, et al. Prediction of survival in patients with metastases in the spinal column - Results based on a randomized trial of radiotherapy [J]. Cancer, 2005, 103 (2): 320-328.
27 Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system [J]. Clin Orthop Relat Res, 1993 (286): 241-246.
28 Swanson KC, Pritchard DJ, Sim FH. Surgical treatment of metastatic disease of the femur [J]. J Am Acad Orthop Surg, 2000, 8(1): 56-65.
29 Ward WG, Spang J, Howe D. Metastatic disease of the femur. Surgical management [J]. J Orthop Clin North Am, 2000, 31(4): 633-645.
30 Moon B, Lin P, Satcher R, et al. Intramedullary nailing of femoral diaphyseal metastases: is it necessary to protect the femoral neck? [J]. Clin Orthop Relat Res, 2015, 473(4): 1499-1502.
31 Ofluoglu O, Erol B, Ozgen Z, et al. Minimally invasive treatment of pathological fractures of the humeral shaft [J]. Int Orthop, 2009, 33 (3): 707-712.
32 Aponte-Tinao LA, Ayerza MA, Muscolo DL, et al. Should fractures in massive intercalary bone allografts of the lower limb be treated with ORIF or with a new allograft? [J]. Clin Orthop Relat Res, 2015, 473(3): 805-811.
33 Bus MP, Dijkstra PD, Van De Sande MA, et al. Intercalary allograft reconstructions following resection of primary bon tumors [J]. J Bone Joint Surg Am, 2014, 96(4): 00655.
34 Han CS, Wood MB, Bishop AT, et al. Vascularized bone tannsfer [J]. J Bone Joint Surg Am, 1992, 74(10): 1441-1449.
35 Tsuchiya H, Wan SL, Sakayama K, et al. Reconstruction using an autograft containing tumour treated by liquid Nitrogen [J]. J Bone Joint Surg Br, 2005, 87(2): 218-225.
36 Ahlmann ER, Menendez LR. Intercalary endoprosthetic Reconstruction for diaphyseal bone tumours [J]. J Bone Joint Surg Br, 2006, 88(11): 1487-1491.
37 Aldlyami E, Abudu A, Grimer RJ, et al. Endoprosthetic replacement of diaphyseal bone defects. Long-term results [J]. Int Orthop, 2005, 29(1): 25-29.
38 Zhao SC, Zhang CQ, Zhang CL. Custom- made intercalary endoprosthetic Reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report [J]. Oncol Lett, 2015, 10(5): 3279- 3285.

相似文献/References:

[1]李子怡,李玉坤.OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用[J].中华老年骨科与康复电子杂志,2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
 Li Ziyi,Li Yukun.Researching progress and application of OPG-RANK-RANKL signaling pathway in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(04):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
[2]董扬 桑尚 张智长 嵇伟平. 73例四肢转移性骨肿瘤的疗效观察[J].中华老年骨科与康复电子杂志,2018,(05):282.
 Dong Yang,Sang Shang,Zhang Zhichang,et al. Clinical analysis and observation of 73 cases with limb metastatic bone tumor[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):282.
[3]钟志伟,马洁琳,王勇,等.骨促结缔组织增生性纤维瘤的影像诊断与鉴别诊断[J].中华老年骨科与康复电子杂志,2020,(03):165.[doi:10.3877/cma.j.issn.2096-0263.2020.03.008]
 Zhong Zhiwei,Ma Jielin,Wang Yong,et al.Imaging diagnosis and differential diagnosis of desmoplastic fibroma of bone[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2020,(04):165.[doi:10.3877/cma.j.issn.2096-0263.2020.03.008]

备注/Memo

备注/Memo:
天津市卫生局课题(15KG124)
更新日期/Last Update: 2017-07-14